South Shore Resources Inc. (Reduction of harmful greenhouse gases and fuel savings with use of Hydrogen Generating Modules and related accessories to the transportation and automotive industries which are either in development and/or the commercialization stages)
The company has prepared and filed for international patent protection with the assistance of Sim & McBurney, Patent & Trademark Agents, a Patent Cooperation Treaty (PCT) international patent application with the World International Property Organization, which describes the technique by electrolysis to produce oxyhydrogen for its Hydrogen On Demand Hybrid Conversion Kits.
About Envision Solar International, Inc.
Envision Solar is a leading solar planner, architect and inventor designing and deploying clean energy systems globally.
The company was featured by prominent “green” media, including The New York Times and Greentech Media. Reporters lauded Envision Solar for its innovative product line that has potential to change the way Americans view solar technology.
Last May, Envision Solar was chosen by InterPV Magazine as one of the world’s top ten Photovoltaic (PV) Picks for 2010. Envision Solar was selected from a pool of more than 929 companies representing every link of the solar value chain. The list covers ten of the hottest global companies in the PV market, including organizations from Japan and Germany, and the U.S.
About Zamage Digital Art Imaging, Inc.
Zamage Digital and its subsidiary Everdow Software (Beijing) Inc. (Wing Road Software Co., Ltd.) focus on delivery of high-tech software solutions in business management industry. EverdowCRM is a leader in Customer Relationship Management (CRM) software. It is an essential tool for organizations to manage and track their sales and marketing efficiently and effectively.
The company's subsidiary EverdowCRM is assessing the Shenzhen Development Bank's requirements and developing a plan in order to appropriate Everdow's customer relations management software system for the Bank. EverdowCRM sent representatives from their leadership team, including two managers and several technical engineers, who will conduct a thorough analysis of needs and familiarize themselves with the current bank infrastructure. The outputs anticipated from this preliminary stage are the initial budget, timeline and strategy for development and implementation. Recently Zamage Digital reported that the estimated value of this project is RMB 800,000 (approximately US $117,000).
About Novelos Therapeutics, Inc.
Novelos Therapeutics is a biopharmaceutical company developing oxidized glutathione-based compounds for the treatment of cancer and hepatitis.
The company reported positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Alberto Montero, MD, Assistant Professor of Medicine at the Miller School and medical oncologist at Sylvester, is the Principal Investigator.
Breast cancer remains a serious public health concern throughout the world. According to the American Cancer Society, approximately 192,000 women in the U.S. were expected to be diagnosed with breast cancer in 2009, and approximately 41,000 were expected to die from the disease.